PHF6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.45290000533416E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.44899999998671E-07 |
Normal-vs-Stage2 |
4.57220000005254E-06 |
Normal-vs-Stage3 |
3.84739995418215E-09 |
Normal-vs-Stage4 |
2.53199999966647E-07 |
Stage1-vs-Stage2 |
9.368800E-01 |
Stage1-vs-Stage3 |
2.636300E-02 |
Stage1-vs-Stage4 |
3.584200E-01 |
Stage2-vs-Stage3 |
2.129600E-01 |
Stage2-vs-Stage4 |
5.435600E-01 |
Stage3-vs-Stage4 |
6.890800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.57710000509215E-08 |
Normal-vs-AfricanAmerican |
7.64289997956524E-09 |
Normal-vs-Asian |
1.630360E-01 |
Caucasian-vs-AfricanAmerican |
1.514810E-01 |
Caucasian-vs-Asian |
3.369400E-01 |
AfricanAmerican-vs-Asian |
9.292000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.97279999506017E-08 |
Normal-vs-Female |
4.28180000344724E-08 |
Male-vs-Female |
8.358400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.56619999974939E-07 |
Normal-vs-Age(41-60Yrs) |
2.9454999994627E-07 |
Normal-vs-Age(61-80Yrs) |
8.47500003509083E-09 |
Normal-vs-Age(81-100Yrs) |
3.60869999993518E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.158400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.973600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.344400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.229420E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.717590E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.843800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.002900E-03 |
Normal-vs-Grade 2 |
3.13349999947476E-07 |
Normal-vs-Grade 3 |
3.70010000416698E-09 |
Normal-vs-Grade 4 |
4.06630000004959E-07 |
Grade 1-vs-Grade 2 |
5.014000E-01 |
Grade 1-vs-Grade 3 |
6.746000E-02 |
Grade 1-vs-Grade 4 |
1.329760E-01 |
Grade 2-vs-Grade 3 |
2.860400E-02 |
Grade 2-vs-Grade 4 |
2.570400E-01 |
Grade 3-vs-Grade 4 |
9.383400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
7.53350000048947E-07 |
Normal-vs-ccB subtype |
4.87040000551886E-08 |
ccA subtype-vs-ccB subtype |
1.439760E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.10110000012465E-07 |
Normal-vs-N1 |
1.847400E-04 |
N0-vs-N1 |
6.274800E-01 |
|
|